Unknown

Dataset Information

0

Vaginal Progesterone Has No Diabetogenic Potential in Twin Pregnancies: A Retrospective Case-Control Study on 1686 Pregnancies.


ABSTRACT: BACKGROUND:In this study, we aimed to investigate the incidence of gestational diabetes mellitus (GDM) in women who carried twin pregnancies and received vaginal progesterone. METHODS:In this retrospective cohort study, 203 out of 1686 women with twin pregnancies received natural progesterone (200 mg/day between gestational weeks 16 + 0 and 36 + 0) vaginally for ? 4 weeks. The control group consisted of 1483 women with twin pregnancies without progesterone administration. Pearson's Chi squared test, Fisher's exact test, and Student's t-test was used to compare differences between the control and the progesterone-treated groups. A multivariate binary logistic regression was performed to assess relative independent associations on the dependent outcome of GDM incidence. RESULTS:Vaginal progesterone treatment in twin pregnancies had no significant influence on developing GDM (p = 0.662). Higher pre-pregnancy BMI (OR 1.1; p < 0.001), GDM in previous pregnancy (OR 6.0; p < 0.001), and smoking during pregnancy (OR 1.6; p = 0.014) posed an increased risk for developing GDM. CONCLUSION:In twin pregnancies, the use of vaginal progesterone for the prevention of recurrent preterm delivery was not associated with an increased risk of GDM.

SUBMITTER: Rosta K 

PROVIDER: S-EPMC7408737 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Vaginal Progesterone Has No Diabetogenic Potential in Twin Pregnancies: A Retrospective Case-Control Study on 1686 Pregnancies.

Rosta Klara K   Al-Bibawy Katharina K   Al-Bibawy Maria M   Temsch Wilhelm W   Springer Stephanie S   Somogyi Aniko A   Ott Johannes J  

Journal of clinical medicine 20200715 7


<h4>Background</h4>In this study, we aimed to investigate the incidence of gestational diabetes mellitus (GDM) in women who carried twin pregnancies and received vaginal progesterone.<h4>Methods</h4>In this retrospective cohort study, 203 out of 1686 women with twin pregnancies received natural progesterone (200 mg/day between gestational weeks 16 + 0 and 36 + 0) vaginally for ≥ 4 weeks. The control group consisted of 1483 women with twin pregnancies without progesterone administration. Pearson'  ...[more]

Similar Datasets

| S-EPMC10072250 | biostudies-literature
| S-EPMC4332976 | biostudies-literature
| S-EPMC6516185 | biostudies-literature
| S-EPMC8002547 | biostudies-literature
| S-EPMC5014197 | biostudies-literature
| S-EPMC10428564 | biostudies-literature
| S-EPMC9358001 | biostudies-literature
| S-EPMC7008526 | biostudies-literature
| S-EPMC8220745 | biostudies-literature